It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

Pfizer

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Observers puzzled by delays in China's approval of BioNTech-Pfizer vaccine

Asia Pacific Aug 30, 2021

Observers puzzled by delays in China's approval of BioNTech-Pfizer vaccine

Some believe Beijing may be concerned that approval of the BioNTech shot could be interpreted as an acknowledgment that local shots are less effective than Western ones.

Here’s how to treat COVID-19 vaccine side effects

Lifestyle Aug 22, 2021

Here’s how to treat COVID-19 vaccine side effects

by Haruka Murayama

There's no guarantee that you'll experience side effects from your COVID-19 vaccination, but it doesn't hurt to be prepared for them anyway.

Pfizer COVID-19 vaccine poised to get full U.S. approval next week

World Aug 21, 2021

Pfizer COVID-19 vaccine poised to get full U.S. approval next week

President Joe Biden believes the approval will help woo more Americans to get the shot. Pfizer’s vaccine has been in use in the U.S. based on an emergency authorization.

Health ministry panel approves AstraZeneca’s vaccine for people 40 and over

National Jul 30, 2021

Health ministry panel approves AstraZeneca’s vaccine for people 40 and over

by Osamu Tsukimori

The panel also backed a proposal to make the shot available to people under age 40 who wish to get AstraZeneca’s jab or who are allergic to the ingredients of the mRNA vaccines.

Even with delta surging, experts say two vaccine doses is enough for now

National Jul 29, 2021

Even with delta surging, experts say two vaccine doses is enough for now

by Osamu Tsukimori

U.S. firm Pfizer Inc. has called for an additional third shot of its COVID-19 vaccine, citing new data showing its efficacy tails off after six months.

Two doses of Pfizer or AstraZeneca shots effective against delta variant, study finds

World Jul 22, 2021

Two doses of Pfizer or AstraZeneca shots effective against delta variant, study finds

The study reiterated that one shot of the vaccines is not enough for high protection from the highly transmissible variant.

Most major cities in Japan revise vaccine plans amid supply crunch

National Jul 18, 2021

Most major cities in Japan revise vaccine plans amid supply crunch

A total of 33 prefectural capitals said the amount of doses allocated for July remains less than half the desired amount.

World carved up into haves and have-nots by mRNA vaccine access

World | FOCUS Jul 16, 2021

World carved up into haves and have-nots by mRNA vaccine access

by Bruce Einhorn

The cutting-edge technology, which made its debut during the pandemic, has proven more effective than any other in staving off infections and serious illness from the coronavirus.

Pfizer bid for booster vaccines premature, experts say, with more data needed

World | ANALYSIS Jul 13, 2021

Pfizer bid for booster vaccines premature, experts say, with more data needed

by Julie Steenhuysen and Michael Erman

The drugmaker's push for health regulators to authorize a third dose of its COVID-19 shot is not yet backed by evidence, despite the fast-spreading delta variant, vaccine experts said.

Pfizer outlines booster plans while regulators signal caution

World Jul 9, 2021

Pfizer outlines booster plans while regulators signal caution

Pfizer Inc. plans to request U.S. emergency authorization in August for a third booster dose of its COVID-19 vaccine.

Pfizer shot halts severe illness in Israel as delta variant spreads

World Jul 6, 2021

Pfizer shot halts severe illness in Israel as delta variant spreads

However, the vaccine's ability to protect people against COVID-19 dropped to 64% between June 6 and early July, down from a previous 94%.

Pfizer and Moderna vaccines likely produce long-lasting immunity

World Jun 28, 2021

Pfizer and Moderna vaccines likely produce long-lasting immunity

by Apoorva Mandavilli

The findings add to growing evidence that most people immunized with mRNA vaccines may not need boosters, so long as the virus and its variants do not evolve much.

« 1 … 5 6 7 … 13 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times